Latigo preps IPO to fund non-opioid rival to Vertex’s Journax
Latigo preps IPO to fund non-opioid rival to Vertex’s Journax.
News Archive
Browse all past biotechnology intelligence, clinical developments, and industry updates.
Archived Updates
Biogen’s mixed Alzheimer’s data; Two new startups launch; and more
Biogen’s mixed Alzheimer’s data; Two new startups launch; and more.
Celcuity got its cancer drug approved. Then its stock dipped
Celcuity got its cancer drug approved. Then its stock dipped.
Midsized biotechs take case against CMS' GLOBE and GUARD models to White House
Midsized biotechs take case against CMS' GLOBE and GUARD models to White House.
Salus Scientific Welcomes Landmark Multi-Society Consensus Statement Advancing the Standard of Care for Severe Burn Injuries
Salus Scientific issued a statement welcoming a multi-society consensus statement that advances the standard of care for severe burn injuries; the company markets burn-care and resuscitation products.
Salus Scientific Welcomes Landmark Multi-Society Consensus Statement Advancing the Future of Occupational Radiation Safety
Salus Scientific Welcomes Landmark Multi-Society Consensus Statement Advancing the Future of Occupational Radiation Safety.
2026 IPO stock tracker: How biotechs new to public markets are performing
BioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
5 emerging biotech hubs
Fierce Biotech profiles five emerging biotech hubs to watch.
ANF Care™ Brings New Wearable Technology to the United States
ANF Care announced US market entry for its ANF Care wearable therapeutic device, expanding availability of its frequency-based wearable technology to American patients and clinicians.
APhA urges FDA to put patient safety first in review of peptide substances
The American Pharmacists Association (APhA) submitted formal comments to the FDA urging the agency to prioritize patient safety in its ongoing review of peptide substances, including compounded and bulk-drug substances.
Arbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances
Arbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances.
BlossomHill eyes IPO to grow taller in crowded cancer fields
BlossomHill eyes IPO to grow taller in crowded cancer fields.
BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with New Topical Skin Closure Solution
BRIJ Medical announced the US launch of BRIJ-SEAL™, a topical skin closure product, expanding the company's incision management portfolio alongside its existing wound-closure and post-operative care products.
BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with an Advanced Wound Sealant
BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with an Advanced Wound Sealant.
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Camurus announces that the FDA has accepted for review its NDA resubmission for CAM2029 in acromegaly.